Compounding Pharmacies Market | Coherent Market Insights

1
Coherent Marketing Insights

• Market Research Business Consulting Services

• https//www.coherentmarketinsights.com/

• Covid-19 Impact Tracker

2

• COMPOUNDING PHARMACIES MARKET ANALYSIS
• Compounding Pharmacies Market, By Products (Oral
  Medication (Capsule, Tablets, Mixtures,
  Lollipops, Lozenges), Topical Medication (Gels,
  Ointments, Cream, Lotions), Mouthwashes,
  Suppositories), By Application (Medication for
  Adults, Medication for Veterinary, Medication for
  Children, Medication for Geriatric), By
  Therapeutic Area (Pain Management, Hormone
  Replacement Therapy), By Region (North America,
  Latin America, Europe, Asia Pacific, Middle East,
  Africa) - Size, Share, Outlook, and Opportunity
  Analysis, 2019 - 2027

3

• A pharmacy that is operated by a licensed
  pharmacist, licensed physician or a person under
  the guidance of a licensed pharmacist is called
  compounding pharmacy.
• Statistics
• The global compounding pharmacies market is
  estimated to account for US 13,304.8 Mn in terms
  of value by the end of 2027.
• Figure 1. Global Compounding Pharmacies Market
  Value (US Mn), by Region, 2018

4

• Global Compounding Pharmacies Market Restraints
• Increasing restrictions on manufacturing of
  complex formulations is expected to hinder growth
  of the global compounding pharmacies market. For
  instance, the U.S. FDA noted that compounding
  drugs containing API acetaminophen in excess of
  325mg, which may lead to liver injuries in
  certain patients. Therefore, it restricts
  compounding pharmacies from manufacturing certain
  types of drugs that include copies of
  FDA-approved prescription drugs, even if they
  appear on FDAs shortage list and complex dosage
  forms such as extended release products,
  transdermal patches, liposomal products, and most
  biologics.
• Moreover, increasing product recall is also
  expected to hinder growth of the market. For
  instance, in August 2019, the U.S. FDA requested
  recall of sterile compounded drug products
  produced by Pacifico National Inc. and dba AmEx
  Pharmacy.

5

• Global Compounding Pharmacies Market
  Opportunities
• RD of drugs in innovative medium/forms and
  varying dosages for the treatment of various
  diseases is expected to offer lucrative growth
  opportunity of market players. For instance, in
  November 2018, AMC, a hospital in Amsterdam
  focused on producing compounding drugs, received
  permission from the Dutch Health and Youth Care
  Inspectorate to produce an equivalent of
  chenodeoxycholic acid (CDCA) if the used
  resources meet the quality standards.
• Moreover, compounding pharmacies need to adopt
  hybrid retail formats along with a compounding
  department in order to diversify their business
  base. Compounding pharmacies can also focus more
  on non-sterile compounding to avoid mishaps due
  to sterile compounding.

6
Global Compounding Pharmacies Market Market
Trends/Key Takeaways

• Hospitals in the U.S. are expected to increase
  outsourcing of compounding services to the U.S.
  FDA 503B-certified bulk drug manufacturing
  facilities in the U.S.
• The market is also witnessing development of
  innovative pain management compounded drugs,
  constituting of unique and currently unapproved
  combinations. These medications are expected to
  witness increasing demand from sports medicines
  and oncology domains.
• Global Compounding Pharmacies Market Regulations
• The EU Court of Justice is currently
  contemplating on mandating that bulk drug
  substances cannot be manufactured by compounding
  pharmacies unless they possess a proper
  manufacturing authorization. These should be
  accompanied with proper toxicity and
  pharmacovigilance data. In this regard, France is
  planning to permit pharmacists to substitute
  cheaper biosimilars on production of
  prescriptions for biologics

7
Global Compounding Pharmacies Market Competitive
Landscape

• Major players operating in the global compounding
  pharmacies market include, Central Admixture
  Pharmacy Services, Fagron, Fresenius Kabi AG,
  PharMEDium Services, LLC, Institutional Pharmacy
  Solutions, Cantrell Drug Company, Triangle
  Compounding Pharmacies, and Lorraines Pharmacy.
• Global Compounding Pharmacies Market Key
  Developments
• Key players in the market are focused on
  geographical expansion through MA activities.
  For instance, in May 2019, Fagron entered into an
  agreement to acquire Central de Drogas, S.A. de
  C.V., a leading supplier of raw materials to
  compounding pharmacies and the pharmaceutical
  industry in Mexico.
• In April 2019, Pentec Health, Inc., an
  established leader in sterile compounding with an
  FDA registered 503B Outsourcing Facility, added
  California to their list of 43 licensed states.

8

• Request Sample Report
• Request Customization
• Download PDF Brochure
• Talk to Analyst
• Referance https//www.coherentmarketinsights.com/
  market-insight/compounding-pharmacies-market-3199

9
About Us

• Coherent Market Insights is a global market
  intelligence and consulting organization focused
  on assisting our plethora of clients achieve
  transformational growth by helping them make
  critical business decisions. We are headquartered
  in India, having office at global financial
  capital in the U.S. Our client base includes
  players from across all business verticals in
  over 150 countries worldwide.
• What We ProvideCustomized Market Research
  AnalysisIndustry Analysis ServicesBusiness
  Consulting ServicesLong Term Engagement
  ModelCountry Specific Analysis

10
Contact Us

• Mr. Shah
• Coherent Market Insights Pvt. LTD.Coherent
  Market Insights 1001 4th Ave, 3200 Seattle, WA
  98154, U.S.Phone [phone]
• Email sales_at_coherentmarketinsights.com

11
Thank You

• Kindly Follow CMI Social Media Profiles for the
  latest Company Updates.
• Facebook
• Linkedin
• Twitter
• https//www.coherentmarketinsights.com/